Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timo F W Soeterik

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
The Journal of Urology|April 13, 2023
Unilateral Pelvic Lymph Node Dissection in Prostate Cancer Patients Diagnosed in the Era of Magnetic Resonance Imaging-targeted Biopsy: A Study That Challenges the DogmaAlberto Martini, Lieke Wever, Timo F W Soeterik, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 11, 2025
oDigital pathology biomarkers for guiding radiotherapy-based treatment concepts in prostate cancer - a systematic review and expert consensusConstantinos Zamboglou, William De Doncker, Andreas Thomas Christoforou, et al.
The Lancet. Oncology|March 12, 2026
New prostate cancer risk groups by PSMA-PET (PPP3): an international, retrospective, registry-based cohort studyMadeleine J Karpinski, Caner Civan, Isabel Rauscher, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
The Journal of Urology|April 13, 2023
Unilateral Pelvic Lymph Node Dissection in Prostate Cancer Patients Diagnosed in the Era of Magnetic Resonance Imaging-targeted Biopsy: A Study That Challenges the DogmaAlberto Martini, Lieke Wever, Timo F W Soeterik, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 11, 2025
oDigital pathology biomarkers for guiding radiotherapy-based treatment concepts in prostate cancer - a systematic review and expert consensusConstantinos Zamboglou, William De Doncker, Andreas Thomas Christoforou, et al.
The Lancet. Oncology|March 12, 2026
New prostate cancer risk groups by PSMA-PET (PPP3): an international, retrospective, registry-based cohort studyMadeleine J Karpinski, Caner Civan, Isabel Rauscher, et al.
Pageof 6